CIK 0000034956
- Non-accelerated filer
- Smaller reporting company
TENAX THERAPEUTICS, INC.
Sign in to watch- Ticker
- TENX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262593535
- Phone
- +1 919-855-2100
- Business address
- 101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC, 27517
- Former names
- OXYGEN BIOTHERAPEUTICS, INC., SYNTHETIC BLOOD INTERNATIONAL INC
- 3 Insider Initial Statement of Ownership
- 4 Gift Director gave 567,871 shares (gift)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Chief Medical Officer acquired 3,581,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 3,070,000 shares (option exercise)
- 4 Grant or award Director acquired 512,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Medical Officer acquired 666,098 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 32,000 shares at an average $1.42 ($45,547)
- 4 Open-market buy Director bought 86,000 shares at an average $1.43 ($123,240)
- 4 Open-market buy Director bought 32,000 shares at an average $1.47 ($47,000)
Page 4 of 11 · 206 filings